Risk minimisation material: Vyndaqel (tafamidis) – Healthcare Professional Guide

This guide includes a checklist for healthcare professionals to go through with patients to ensure that all the criteria are met for the diagnosis of transthyretin amyloid cardiomyopathy before prescribing, and to warn of potential adverse effects.

Source:

Pfizer